1.PG2 Lyophilized Injection: PG2 Lyo. Injection was the 1st TFDA-approved Botanical New Drug in Taiwan for treating Cancer-Related Fatigue. The follow-up studies after launching focus on immune-modulation effects、anti-inflammation、adjuvant chemotherapy and searching for the biomarker for Cancer-Related Fatigue. A Phase II clinical trial treating ITP (Idiopathic Thrombocytopenic Purpura), an orphan disease, was also completed.
2. PHN031: The Phase IIa clinical trial was approved by the US FDA have been completed for the prevention of osteoporosis and was chosen to be the Cross-Strait Drug Co-Development Project.
3. PHN033: The Phase IIa clinical trial which was approved by US FDA have been completed for the treatment of diabetic nephropathy and was chosen to be the Cross-Strait Drug Co-Development Project.
4. Oraphine® Soft Capsule: A commercially available narcotic drug with new route of administration (from injection to oral administration) for treating Moderated to Severe Pain. The NDA (new drug application ) has been filed with the TFDA for the drug registration
5.NatoCleanse : "NatoCleanse" has been awarded with a Certificate of Health Food by TFDA (App. No#A00092)
6. ReyeasCleanse: "ReyeasCleanse" has been awarded with a Certificate of Health Food by TFDA (App. No#000006)
Assurance services
Tax services
Deals services
Legal services
Consulting services
People and change services
1. Vital-View® Lutein capsules
2. Vital-View II® Lutein capsules
3. Real-Free® Probiotics capsule